サマリー

ヘパリンの世界市場 2023-2027
Technavioはヘパリン市場を監視しており、2023年から2027年にかけて3億944万ドルの成長が見込まれ、予測期間中にCAGR 6.94％で加速しています。当レポートでは、ヘパリン市場の全体的な分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、凝固障害の有病率の増加、慢性疾患の増加、ヘパリン製造のための代替ソースの再導入によって牽引されています。
Technavioのヘパリン市場は以下のようにセグメント化されています。
製品別
- 低分子ヘパリン
- その他
投与経路別
- 皮下注射
- 静脈注射・輸液
地域別構成比
- 欧州
- 北アメリカ
- アジア
- その他の地域 (ROW)
本調査では、今後数年間のヘパリン市場の成長を促進する主な理由の一つとして、ヘパリンの研究開発活動の増加と新たな治療用途を挙げています。また、バイオシミラー低分子ヘパリンの登場や、手術後にヘパリンを除去するための薬剤の開発なども、市場の大きな需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。ヘパリン市場に関する当レポートの対象領域は以下の通りです。
- ヘパリン市場のサイジング
- ヘパリン市場の予測
- ヘパリン市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Aspen Pharmacare Holdings、B. Braun SE、Baxter International Inc.、Dr Reddys Laboratories Ltd.、Eisai Co., Ltd.など、いくつかの主要ヘパリン市場ベンダーに関する詳細分析を提供します。Ltd.、Fresenius SE and Co.KGaA、Hebei Changshan Biochemical、Hikma Pharmaceuticals Plc、Laboratorios Farmaceuticos Rovi、LEO Pharma AS、Nanjing Kingfriend Biochemical、Nichi Iko Pharmaceutical Co.また、このような環境下において、当社グループは、「環境・社会貢献活動」を積極的に推進してまいります。Ltd.、Shenzhen Techdow Pharmaceutical、Teva Pharmaceutical Industries Ltd.、Viatris Inc.の7社です。また、ヘパリン市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/heparin-market-industry-analysis をご覧ください。
Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析を通じて、複数のソースからのデータの調査、合成、総括により、市場の詳細な姿を提示します。業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global heparin market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global heparin market 2017 - 2021 ($ million)
o 4.2 Product Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
o 4.3 Route of administration Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Route of administration Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Low-molecular-weight heparin - Market size and forecast 2022-2027
o Exhibit 34: Chart on Low-molecular-weight heparin - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Low-molecular-weight heparin - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Low-molecular-weight heparin - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Low-molecular-weight heparin - Year-over-year growth 2022-2027 (%)
o 6.4 Others - Market size and forecast 2022-2027
o Exhibit 38: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
• 7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 43: Chart on Route of Administration - Market share 2022-2027 (%)
o Exhibit 44: Data Table on Route of Administration - Market share 2022-2027 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 45: Chart on Comparison by Route of Administration
o Exhibit 46: Data Table on Comparison by Route of Administration
o 7.3 Subcutaneous injection - Market size and forecast 2022-2027
o Exhibit 47: Chart on Subcutaneous injection - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Subcutaneous injection - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Subcutaneous injection - Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Subcutaneous injection - Year-over-year growth 2022-2027 (%)
o 7.4 Intravenous/infusion - Market size and forecast 2022-2027
o Exhibit 51: Chart on Intravenous/infusion - Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Intravenous/infusion - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Intravenous/infusion - Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Intravenous/infusion - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Route of Administration
o Exhibit 55: Market opportunity by Route of Administration ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 59: Chart on Geographic comparison
o Exhibit 60: Data Table on Geographic comparison
o 9.3 Europe - Market size and forecast 2022-2027
o Exhibit 61: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 63: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 64: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.4 North America - Market size and forecast 2022-2027
o Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 81: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 France - Market size and forecast 2022-2027
o Exhibit 93: Chart on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on France - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on France - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 97: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 98: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 100: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 101: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 102: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 103: Matrix on vendor position and classification
o 12.3 Aspen Pharmacare Holdings
o Exhibit 104: Aspen Pharmacare Holdings - Overview
o Exhibit 105: Aspen Pharmacare Holdings - Business segments
o Exhibit 106: Aspen Pharmacare Holdings - Key offerings
o Exhibit 107: Aspen Pharmacare Holdings - Segment focus
o 12.4 B. Braun SE
o Exhibit 108: B. Braun SE - Overview
o Exhibit 109: B. Braun SE - Business segments
o Exhibit 110: B. Braun SE - Key news
o Exhibit 111: B. Braun SE - Key offerings
o Exhibit 112: B. Braun SE - Segment focus
o 12.5 Baxter International Inc.
o Exhibit 113: Baxter International Inc. - Overview
o Exhibit 114: Baxter International Inc. - Business segments
o Exhibit 115: Baxter International Inc. - Key news
o Exhibit 116: Baxter International Inc. - Key offerings
o Exhibit 117: Baxter International Inc. - Segment focus
o 12.6 Eisai Co. Ltd.
o Exhibit 118: Eisai Co. Ltd. - Overview
o Exhibit 119: Eisai Co. Ltd. - Business segments
o Exhibit 120: Eisai Co. Ltd. - Key offerings
o Exhibit 121: Eisai Co. Ltd. - Segment focus
o 12.7 Fresenius SE and Co. KGaA
o Exhibit 122: Fresenius SE and Co. KGaA - Overview
o Exhibit 123: Fresenius SE and Co. KGaA - Business segments
o Exhibit 124: Fresenius SE and Co. KGaA - Key news
o Exhibit 125: Fresenius SE and Co. KGaA - Key offerings
o Exhibit 126: Fresenius SE and Co. KGaA - Segment focus
o 12.8 Hikma Pharmaceuticals Plc
o Exhibit 127: Hikma Pharmaceuticals Plc - Overview
o Exhibit 128: Hikma Pharmaceuticals Plc - Business segments
o Exhibit 129: Hikma Pharmaceuticals Plc - Key offerings
o Exhibit 130: Hikma Pharmaceuticals Plc - Segment focus
o 12.9 Laboratorios Farmaceuticos Rovi
o Exhibit 131: Laboratorios Farmaceuticos Rovi - Overview
o Exhibit 132: Laboratorios Farmaceuticos Rovi - Business segments
o Exhibit 133: Laboratorios Farmaceuticos Rovi - Key offerings
o Exhibit 134: Laboratorios Farmaceuticos Rovi - Segment focus
o 12.10 Nanjing Kingfriend Biochemical
o Exhibit 135: Nanjing Kingfriend Biochemical - Overview
o Exhibit 136: Nanjing Kingfriend Biochemical - Product / Service
o Exhibit 137: Nanjing Kingfriend Biochemical - Key offerings
o 12.11 Nichi Iko Pharmaceutical Co. Ltd.
o Exhibit 138: Nichi Iko Pharmaceutical Co. Ltd. - Overview
o Exhibit 139: Nichi Iko Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 140: Nichi Iko Pharmaceutical Co. Ltd. - Key offerings
o 12.12 Novartis AG
o Exhibit 141: Novartis AG - Overview
o Exhibit 142: Novartis AG - Business segments
o Exhibit 143: Novartis AG - Key offerings
o Exhibit 144: Novartis AG - Segment focus
o 12.13 Pfizer Inc.
o Exhibit 145: Pfizer Inc. - Overview
o Exhibit 146: Pfizer Inc. - Product / Service
o Exhibit 147: Pfizer Inc. - Key news
o Exhibit 148: Pfizer Inc. - Key offerings
o 12.14 Sanofi SA
o Exhibit 149: Sanofi SA - Overview
o Exhibit 150: Sanofi SA - Business segments
o Exhibit 151: Sanofi SA - Key news
o Exhibit 152: Sanofi SA - Key offerings
o Exhibit 153: Sanofi SA - Segment focus
o 12.15 Shenzhen Techdow Pharmaceutical
o Exhibit 154: Shenzhen Techdow Pharmaceutical - Overview
o Exhibit 155: Shenzhen Techdow Pharmaceutical - Product / Service
o Exhibit 156: Shenzhen Techdow Pharmaceutical - Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 157: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 158: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 160: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 161: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 Viatris Inc.
o Exhibit 162: Viatris Inc. - Overview
o Exhibit 163: Viatris Inc. - Business segments
o Exhibit 164: Viatris Inc. - Key offerings
o Exhibit 165: Viatris Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 166: Inclusions checklist
o Exhibit 167: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 168: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 169: Research methodology
o Exhibit 170: Validation techniques employed for market sizing
o Exhibit 171: Information sources
o 13.5 List of abbreviations
o Exhibit 172: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global heparin market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Route of administration Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Low-molecular-weight heparin - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Low-molecular-weight heparin - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Low-molecular-weight heparin - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Low-molecular-weight heparin - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits44: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Route of Administration
Exhibits46: Data Table on Comparison by Route of Administration
Exhibits47: Chart on Subcutaneous injection - Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Subcutaneous injection - Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Subcutaneous injection - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Subcutaneous injection - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Intravenous/infusion - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Intravenous/infusion - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Intravenous/infusion - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Intravenous/infusion - Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Route of Administration ($ million)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits62: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits63: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits97: Market opportunity By Geographical Landscape ($ million)
Exhibits98: Impact of drivers and challenges in 2022 and 2027
Exhibits99: Overview on Criticality of inputs and Factors of differentiation
Exhibits100: Overview on factors of disruption
Exhibits101: Impact of key risks on business
Exhibits102: Vendors covered
Exhibits103: Matrix on vendor position and classification
Exhibits104: Aspen Pharmacare Holdings - Overview
Exhibits105: Aspen Pharmacare Holdings - Business segments
Exhibits106: Aspen Pharmacare Holdings - Key offerings
Exhibits107: Aspen Pharmacare Holdings - Segment focus
Exhibits108: B. Braun SE - Overview
Exhibits109: B. Braun SE - Business segments
Exhibits110: B. Braun SE - Key news
Exhibits111: B. Braun SE - Key offerings
Exhibits112: B. Braun SE - Segment focus
Exhibits113: Baxter International Inc. - Overview
Exhibits114: Baxter International Inc. - Business segments
Exhibits115: Baxter International Inc. - Key news
Exhibits116: Baxter International Inc. - Key offerings
Exhibits117: Baxter International Inc. - Segment focus
Exhibits118: Eisai Co. Ltd. - Overview
Exhibits119: Eisai Co. Ltd. - Business segments
Exhibits120: Eisai Co. Ltd. - Key offerings
Exhibits121: Eisai Co. Ltd. - Segment focus
Exhibits122: Fresenius SE and Co. KGaA - Overview
Exhibits123: Fresenius SE and Co. KGaA - Business segments
Exhibits124: Fresenius SE and Co. KGaA - Key news
Exhibits125: Fresenius SE and Co. KGaA - Key offerings
Exhibits126: Fresenius SE and Co. KGaA - Segment focus
Exhibits127: Hikma Pharmaceuticals Plc - Overview
Exhibits128: Hikma Pharmaceuticals Plc - Business segments
Exhibits129: Hikma Pharmaceuticals Plc - Key offerings
Exhibits130: Hikma Pharmaceuticals Plc - Segment focus
Exhibits131: Laboratorios Farmaceuticos Rovi - Overview
Exhibits132: Laboratorios Farmaceuticos Rovi - Business segments
Exhibits133: Laboratorios Farmaceuticos Rovi - Key offerings
Exhibits134: Laboratorios Farmaceuticos Rovi - Segment focus
Exhibits135: Nanjing Kingfriend Biochemical - Overview
Exhibits136: Nanjing Kingfriend Biochemical - Product / Service
Exhibits137: Nanjing Kingfriend Biochemical - Key offerings
Exhibits138: Nichi Iko Pharmaceutical Co. Ltd. - Overview
Exhibits139: Nichi Iko Pharmaceutical Co. Ltd. - Product / Service
Exhibits140: Nichi Iko Pharmaceutical Co. Ltd. - Key offerings
Exhibits141: Novartis AG - Overview
Exhibits142: Novartis AG - Business segments
Exhibits143: Novartis AG - Key offerings
Exhibits144: Novartis AG - Segment focus
Exhibits145: Pfizer Inc. - Overview
Exhibits146: Pfizer Inc. - Product / Service
Exhibits147: Pfizer Inc. - Key news
Exhibits148: Pfizer Inc. - Key offerings
Exhibits149: Sanofi SA - Overview
Exhibits150: Sanofi SA - Business segments
Exhibits151: Sanofi SA - Key news
Exhibits152: Sanofi SA - Key offerings
Exhibits153: Sanofi SA - Segment focus
Exhibits154: Shenzhen Techdow Pharmaceutical - Overview
Exhibits155: Shenzhen Techdow Pharmaceutical - Product / Service
Exhibits156: Shenzhen Techdow Pharmaceutical - Key offerings
Exhibits157: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits158: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits159: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits160: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits161: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits162: Viatris Inc. - Overview
Exhibits163: Viatris Inc. - Business segments
Exhibits164: Viatris Inc. - Key offerings
Exhibits165: Viatris Inc. - Segment focus
Exhibits166: Inclusions checklist
Exhibits167: Exclusions checklist
Exhibits168: Currency conversion rates for US$
Exhibits169: Research methodology
Exhibits170: Validation techniques employed for market sizing
Exhibits171: Information sources
Exhibits172: List of abbreviations